GGrantIndex
Sort

64,565 grants matching drug discovery

Identifying mechanisms by which metformin regulates T cell responses in obesity

$753,296
Nancie Maciver · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DK

Gene discovery in multi-ethnic late-onset Alzheimer's disease families

$753,291
Badri N Vardarajan · Columbia University Health Sciences · U01 · FY2024 · AG

Novel DFG out inhibitors of Abl-kinases to treat PML

$753,121
Milton H. Werner · Inhibikase Therapeutics · R44 · FY2015 · AI

A fluorescent reporter detecting precise homologous recombination transgenesis activity

$752,994
Trisha Brock · Kdt, Inc · R44 · FY2019 · HD

New antifungals targeting the synthesis of fungal sphingolipids

$752,843
Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2025 · AI

Gene discovery in multi-ethnic late-onset Alzheimer's disease families

$752,709
Badri N Vardarajan · Columbia University Health Sciences · U01 · FY2023 · AG

Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance

$752,693
Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

CATALYTIC METHODS FOR ORGANIC SYNTHESIS

$752,610
Massachusetts Institute Of Technology · R37 · FY2004 · GM

Contributions of autophagy-related genes in lupus

$752,587
Swapan K Nath · Oklahoma Medical Research Foundation · R01 · FY2023 · AI

Countermeasures for Bioterroism Targeting Cellular Host Factors

$752,492
John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2010 · AI

Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase

$752,413
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · AG

Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase

$752,413
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · AG

Molecular, Cellular, and Tissue Characterization Unit

$752,398
Joe W. Gray · Oregon Health & Science University · U2C · FY2022 · CA

Optimization of novel phenotypic screening hits for treatment of Malaria

$752,336
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2021 · AI

Carisbamate Treatment for Alcohol Dependence

$752,317
Thomas Frederick Newton · Medications Discovery Texas, Inc. · R42 · FY2013 · AA

Discovery of mGlu receptor PAMs for treatment of schizophrenia

$752,218
P Jeffrey Conn · Vanderbilt University · R01 · FY2019 · MH

Discovery of mGlu receptor PAMs for treatment of schizophrenia

$752,218
P Jeffrey Conn · Vanderbilt University · R01 · FY2020 · MH

Discovery through chemical synthesis of antibiotics effective against modern bacterial pathogens

$752,182
Andrew G Myers · Harvard University · R01 · FY2023 · AI

Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC

$752,151
Francis X McCormack · University Of Cincinnati · U01 · FY2016 · HL

Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease

$752,150
Rebekah L. Gundry · University Of Nebraska Medical Center · R35 · FY2024 · HL

Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery

$751,987
Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI

Improving vaccine development through high-throughput immunogenicity screening.

$751,913
Benjamin Delbert Brooks · Carterra, Inc. · R44 · FY2016 · AI

Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRD

$751,893
Rui Zhang · University Of Minnesota · R01 · FY2025 · AG

Discovery of Addiction-Related Genes with Advanced Mouse Resources

$751,802
Elissa J Chesler · Jackson Laboratory · R01 · FY2016 · DA

Biological Magnetic Resonance Data Bank

$751,767
Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · R24 · FY2023 · GM